Melatonin for Pulmonary Hypertension in Full Term Neonates

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

December 15, 2024

Study Completion Date

March 15, 2025

Conditions
Neonatal Diseases and AbnormalitiesNeonatal MortalityPulmonary Arterial HypertensionPulmonary Arterial Hypertension, Children
Interventions
DRUG

Melatonin

oral melatonin 3 mg/kg/day divided in 3 doses , after enteral feeding, for 3 consecutive days, as combined therapy to milrinone

OTHER

Placebo

Equivalent amount of distilled water will be given every hours as combined therapy to milrinone

Trial Locations (1)

Unknown

Ain shams university, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06685679 - Melatonin for Pulmonary Hypertension in Full Term Neonates | Biotech Hunter | Biotech Hunter